MétaCan
Menu
Back to cohort
Record W4367051560 · doi:10.1002/path.6082

Receptor for hyaluronan‐mediated motility ( <scp>RHAMM</scp> ) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients

2023· article· en· W4367051560 on OpenAlexafffund
Sarah E Tarullo, Yuyu He, Claire Daughters, Todd P. Knutson, Christine Henzler, Matt A. Price, Ryan Shanley, Patrice M. Witschen, Cornelia Tölg, Rachael E. Kaspar, Caroline Hallstrom, Lyubov Gittsovich, Megan L. Sulciner, Xihong Zhang, Colleen L. Forster, Carol A. Lange, Oleg Shats, Michelle Desler, Kenneth H. Cowan, Douglas Yee, Kathryn L. Schwertfeger, Eva A. Turley, James B. McCarthy, Andrew C. Nelson

Bibliographic record

VenueThe Journal of Pathology · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicProteoglycans and glycosaminoglycans research
Canadian institutionsLondon Health Sciences CentreWestern University
FundersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Advancing Translational SciencesNational Institute of General Medical SciencesMasonic Cancer Center, University of MinnesotaNational Cancer InstituteNational Institutes of HealthBreast Cancer Society of CanadaUniversity of MinnesotaElsa U. Pardee FoundationCanadian Institutes of Health ResearchAmerican Cancer SocietyCancer Research Society
KeywordsTumor progressionTumor microenvironmentBreast cancerMetastasisCancer researchCancerMotilityBiologyPathologyImmunologyMedicineInternal medicineCell biology

Abstract

fetched live from OpenAlex

Abstract Breast cancer invasion and metastasis result from a complex interplay between tumor cells and the tumor microenvironment (TME). Key oncogenic changes in the TME include aberrant synthesis, processing, and signaling of hyaluronan (HA). Hyaluronan‐mediated motility receptor (RHAMM, CD168; HMMR ) is an HA receptor enabling tumor cells to sense and respond to this aberrant TME during breast cancer progression. Previous studies have associated RHAMM expression with breast tumor progression; however, cause and effect mechanisms are incompletely established. Focused gene expression analysis of an internal breast cancer patient cohort confirmed that increased RHAMM expression correlates with aggressive clinicopathological features. To probe mechanisms, we developed a novel 27‐gene RHAMM‐related signature (RRS) by intersecting differentially expressed genes in lymph node (LN)‐positive patient cases with the transcriptome of a RHAMM‐dependent model of cell transformation, which we validated in an independent cohort. We demonstrate that the RRS predicts for poor survival and is enriched for cell cycle and TME‐interaction pathways. Further analyses using CRISPR/Cas9‐generated RHAMM −/− breast cancer cells provided direct evidence that RHAMM promotes invasion in vitro and in vivo . Immunohistochemistry studies highlighted heterogeneous RHAMM protein expression, and spatial transcriptomics associated the RRS with RHAMM‐high microanatomic foci. We conclude that RHAMM upregulation leads to the formation of ‘invasive niches’, which are enriched in RRS‐related pathways that drive invasion and could be targeted to limit invasive progression and improve patient outcomes. © 2023 The Authors. The Journal of Pathology published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.120
Threshold uncertainty score0.396

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.290
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations19
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueThe Journal of PathologySame topicProteoglycans and glycosaminoglycans researchFrench-language works237,207